ABOUT US
We Strive for a Better Tomorrow and a Healthier Future.
History
-
2023
AiKPro domestic patent registration
Selected as a Baby Unicorn 200 Incubation Project
Selected as a Industry-Academia Collaboration Drug
Development Support Program (KMEDI hub) -
2022
PanAzent patent application
DDiSTA > AiLNP joint research agreement
with Samyang HoldingsMoliSTA > Daewoong Pharmaceutical & KMEDI hub
-
2021
ER-DDP domestic patent application
Secured lead for MoliSTA-based autoimmune disease therapeutics
Development of AiCPP / AiP450 / AiSAR
-
2020
Series A investment
Development of ER-DDP / PanAzent
Selected as a ‘Tech against COVID-19’ project by Amazon & Rescale
-
2016~2019
Selected as a ‘Artificial Intelligence based Drug Discovery Platform’ project by
Ministry of Science and ICT / Ministry of Health and WelfareDevelopment of artificial intelligence platform iSTA
Development of new drug discovery program based on MoliSTA platform
Selected as a tech startup for TIPS
(Tech Incubator Program for Startup Korea) programSeed investment by Korea Technology Finance Corporation / Certified as
a venture companyDevelopment of ArchiSTA
Establishment of AZothBio